SynthesisFrontiers in psychology2026
Fear of cancer occurrence in breast cancer previvors: a scoping review of the literature.
Synthesis in Frontiers in psychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Objective: Pathogenic variants (PVs) in genes create a unique population of "previvors," individuals who have no personal history of a cancer diagnosis, but carry chronically elevated lifetime cancer risk. PVs in breast cancer previvors negatively impact body image and family planning, and increase uncertainty and anxiety. How fear of cancer occurrence (FOCO) is experienced in previvors is not well described in the literature. This scoping review aimed to describe how FOCO manifests among breast cancer previvors. Methods: Guided by Joanna Briggs Institute (JBI) scoping review methodology, a search was conducted across CINAHL, PsycINFO, PubMed, and Scopus databases. Records were screened and data extracted using Covidence. Inclusion criteria were female sex, presence of a breast cancer PV, no personal history of breast cancer, and description(s) of cancer-related fear. Results: 1,022 records were screened, 10 articles ( Conclusion: FOCO may represent a distinct and clinically important experience to individuals living with an increased predisposition to developing breast cancer. Previvors must navigate both present and future cancer fears, distinguishing them from both average-risk individuals and cancer survivors. However, more research is needed to better characterize and measure FOCO among individuals with an increased risk of developing breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.